ECOR Earnings

ECOR reported its earnings on 2026-03-16, showcasing a revenue of against an estimate of 8.89M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.34 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ECOR's earnings announcement on 2026-03-16, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, ECOR's stock price tends to shift by an average of -1.28% in the 10 days leading up to earnings and -13.74% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate ECOR's annual revenue to reach 9.02M, while the EPS is projected at -0.35. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ECOR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ECOR's stock price typically moves by -1.28% in the 10 days before its earnings and -13.74% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.35 and revenue of 9.02M.

The earnings call reflects mixed signals. Basic financial performance shows slight improvement in adjusted EBITDA net loss, but there's a delay in profitability. Product development is active, but with uncertainties in TAC-STIM and international revenue. Market strategy is cautious, with some success in VA channels. Expenses are increasing, impacting financial health. Shareholder returns are not addressed. Q&A reveals cautious expansion and litigation issues. Overall, the stock price reaction is likely neutral due to balanced positive and negative elements.